Metacognition Questionnaire-30 (MCQ-30)

1. Abstract

The Metacognition Questionnaire-30 (MCQ-30) is an internationally recognized, 30-item self-report psychometric instrument designed to evaluate individual differences in metacognitive beliefs, judgments, and monitoring processes underpinning psychological vulnerability. Developed by Adrian Wells and Sam Cartwright-Hatton (2004) as an efficient, psychometrically refined abbreviation of the original 65-item Metacognitions Questionnaire (MCQ; Cartwright-Hatton & Wells, 1997), the scale operationalizes the core constructs of the Self-Regulatory Executive Function (S-REF) model. The instrument captures five distinct, theoretically derived metacognitive dimensions: (1) Positive Beliefs about Worry, (2) Negative Beliefs about Worry Concerning Uncontrollability and Danger, (3) Cognitive Confidence (reflecting distrust in personal memory and attentional performance), (4) Beliefs about the Need to Control Thoughts, and (5) Cognitive Self-Consciousness (the tendency to monitor and reflect upon cognitive events). Each item is rated on an authentic 4-point Likert scale ranging from 1 (Do not agree) to 4 (Agree very much), yielding subscale scores from 6 to 24 and total global scores from 30 to 120.

Extensive psychometric investigations across clinical, non-clinical, adolescent, and cross-cultural samples confirm that the MCQ-30 possesses robust internal consistency (Cronbach’s alpha coefficients ranging from .72 to .93 across subscales and exceeding .90 for the total score), stable test-retest reliability across diverse intervals, and an invariant five-factor latent structure demonstrated via exploratory and confirmatory factor analyses. The scale demonstrates profound convergent validity through strong associations with measures of generalized anxiety, trait worry, rumination, obsessive-compulsive phenomena, and depressive symptom severity. As the empirical gold standard for assessing maladaptive metacognition, the MCQ-30 serves as a pivotal diagnostic, outcome, and mechanistic evaluation tool in Metacognitive Therapy (MCT) and transdiagnostic psychopathology research.

2. Keywords

Metacognition Questionnaire-30, MCQ-30, metacognitive beliefs, Self-Regulatory Executive Function model, Cognitive Attentional Syndrome, worry, generalized anxiety disorder, cognitive confidence, thought control, psychometrics

3. Authors

The Metacognition Questionnaire-30 was developed and validated by Adrian Wells, Ph.D., and Sam Cartwright-Hatton, D.Phil., D.Clin.Psych.

• Adrian Wells, Ph.D.: Professor of Clinical and Experimental Psychopathology in the Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health at the University of Manchester, United Kingdom. Professor Wells is the originator of Metacognitive Therapy (MCT) and co-developer of the S-REF model of psychological disorders. He is also the director of the Metacognitive Therapy Institute.
• Sam Cartwright-Hatton, D.Phil., D.Clin.Psych.: Professor of Clinical Child Psychology in the School of Psychology at the University of Sussex, United Kingdom. Her research focuses on the developmental etiology of anxiety disorders in children and adolescents, parental metacognition, and cognitive-behavioral interventions.

4. Purpose

The primary purpose of the Metacognition Questionnaire-30 (MCQ-30) is to provide an empirically grounded, concise, and psychometrically robust measurement of dysfunctional metacognitive beliefs and monitoring processes that initiate, intensify, and perpetuate emotional disorders. In contemporary clinical psychology, cognition is traditionally divided into first-order cognitive content (e.g., automatic thoughts, cognitive distortions, core beliefs about the self, world, and future) and second-order metacognition, which pertains to the appraisal, monitoring, and subjective control of cognition itself (Wells, 2000). The MCQ-30 was explicitly engineered to assess these higher-order metacognitive dimensions.

From an applied clinical perspective, the MCQ-30 serves three essential clinical purposes:

• Diagnostic and Case Formulation: In the context of Metacognitive Therapy (MCT), the questionnaire allows clinicians to systematically map an individual’s idiosyncratic metacognitive profile. By pinpointing whether a patient suffers predominantly from positive beliefs about worry (e.g., viewing worry as an indispensable coping strategy) or catastrophic negative beliefs regarding mental uncontrollability and somatic harm, clinicians can formulate targeted behavioral experiments and verbal reattribution strategies.
• Treatment Monitoring and Outcome Assessment: Because symptom reduction in MCT is hypothesized to be mediated by the modification of metacognitive beliefs rather than the reality-testing of individual thought contents, the MCQ-30 functions as an essential repeated-measurement tool. Reductions in subscale scores—particularly negative beliefs regarding uncontrollability and danger—directly correlate with sustained clinical remission across anxiety, depressive, and trauma spectrum disorders.
• Transdiagnostic Psychopathology Research: The scale enables researchers to interrogate common vulnerability pathways across conventionally distinct diagnostic categories. Empirical literature has leveraged the MCQ-30 to uncover how metacognitive dysregulations underpin diverse conditions such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), substance addictions, problem gambling, chronic pain, and psychotic phenomena.

5. Psychological Construct

The psychological construct evaluated by the MCQ-30 is multidimensional metacognition, conceptualized as knowledge, beliefs, and processes concerning human thought processes. Rather than evaluating emotional distress directly (such as depressive affect or somatic anxiety), the instrument isolates five interrelated yet functionally independent metacognitive domains:

1. Positive Beliefs about Worry (POS)

This subscale assesses the degree to which an individual believes that engaging in perseverative conceptual processing (worrying) fulfills an adaptive, protective, or problem-solving function. Individuals scoring high on this dimension conceptualize worry as an indispensable coping mechanism that prepares them for adversity, prevents catastrophes, prevents interpersonal blunders, and facilitates behavioral organization. Representative items include “Worrying helps me to avoid problems in the future” and “Worrying helps me to get things sorted out in my mind.” These beliefs serve as the primary motivational trigger that initiates the Cognitive Attentional Syndrome (CAS) when an individual is confronted with initial intrusive thoughts or external stressors.

2. Negative Beliefs about Worry Concerning Uncontrollability and Danger (NEG)

This dimension taps into catastrophic appraisals regarding the subjective uncontrollability, physical invasiveness, and psychological lethality of perseverative thoughts (also termed ‘type 2 worry’ or ‘meta-worry’). Individuals harboring elevated negative beliefs perceive their internal cognitive flow as involuntary, pathogenic, and capable of driving them into insanity or somatic collapse. Manifested in items such as “My worrying thoughts persist, no matter how I try to stop them” and “My worrying could make me go mad,” this construct is widely recognized as the single strongest metacognitive predictor of clinical anxiety, panic responses, and emotional pathology.

3. Cognitive Confidence (CC)

This subscale measures an individual’s subjective distrust in their cognitive architecture, specifically their memory retrieval, linguistic recall, spatial orientation, and operational mental efficiency. Higher scores reflect marked skepticism toward one’s mental faculties, captured by items like “I have little confidence in my memory for words and names” and “I do not trust my memory.” Notably, psychometric studies demonstrate that objective neuropsychological testing often reveals completely intact memory performance in individuals with elevated CC scores; thus, the subscale reflects a subjective metacognitive deficit in cognitive self-efficacy rather than objective neurological impairment. In clinical cohorts, low cognitive confidence strongly correlates with checking compulsions, reassurance seeking, and repetitive monitoring.

4. Beliefs about the Need to Control Thoughts (NC)

This factor evaluates beliefs that internal thoughts must be rigorously censored, suppressed, or governed under threat of catastrophic responsibility, punishment, or moral failure. It reflects an underlying cognitive perfectionism wherein experiencing an untoward or taboo thought is equated with personal weakness or culpable negligence. Items such as “I should be in control of my thoughts all of the time” and “If I did not control a worrying thought, and then it happened, it would be my fault” typify this dimension. This construct is theoretically adjacent to thought-action fusion and plays a critical role in the pathogenesis of obsessive-compulsive rituals and mental neutralization strategies.

5. Cognitive Self-Consciousness (CSC)

The final subscale operationalizes the structural tendency of an individual to direct focused internal attention toward ongoing cognitive operations. It measures chronic self-monitoring, introspective hypervigilance, and obsessive self-reflection, as illustrated by items like “I monitor my thoughts” and “I am constantly aware of my thinking.” While introspective awareness can be adaptive in moderation, heightened cognitive self-consciousness depletes finite attentional resources, sustains excessive internal monitoring, and exacerbates acute distress by magnifying the salience of benign mental intrusions.

6. Theoretical Framework

The Metacognition Questionnaire-30 is firmly anchored within the theoretical architecture of the Self-Regulatory Executive Function (S-REF) model, articulated by Adrian Wells and Gerald Matthews (1994, 1996). The S-REF model was developed to overcome the limitations of classic cognitive content models (such as Beck’s schema theory), which focus predominantly on the validity or distortion of automated thoughts (e.g., “I am a failure”). In contrast, the S-REF paradigm posits that psychological disorders are initiated and sustained by a toxic, perseverative mode of cognitive processing termed the Cognitive Attentional Syndrome (CAS).

The CAS is characterized by three interdependent cognitive-behavioral phenomena:

1. Perseverative Conceptual Thinking: Repetitive, open-ended mental processing focused on anticipating threat (worry) or dwelling on past losses, deficits, and causal explanations (rumination).
2. Attentional Threat Monitoring: Preferential scanning of both the external environment and internal somatic/cognitive landscapes for cues of danger, vulnerability, or failure.
3. Maladaptive Coping Behaviors: Unhelpful behaviors that backfire and prevent natural cognitive self-regulation, such as thought suppression, situational avoidance, safety-seeking rituals, alcohol or sedative misuse, and compulsions.

Within this framework, human cognitive architecture operates at three structural levels:

• Lower-Level Processing: An automatic, stimulus-driven, non-conscious network that detects discrepancy signals and triggers preconscious intrusions.
• Supervisory Executive Processing (The S-REF Network): A voluntary, resource-demanding executive processing loop that activates strategic cognitive plans in an effort to reduce perceived self-discrepancies.
• Metacognitive Knowledge Base: The long-term memory storehouse containing declarative beliefs (e.g., explicit beliefs about thoughts) and procedural knowledge (plans and heuristic algorithms that govern attentional deployment and mental regulation).

The MCQ-30 specifically measures the content of this long-term metacognitive knowledge base. The S-REF model stipulates that when an individual experiences an intrusive negative thought (e.g., “What if I fail my presentation?”), positive metacognitive beliefs (e.g., “Worrying helps me solve problems”) dictate the selection of perseverative worry as an executive coping strategy. As worry persists, it eventually activates dormant negative metacognitive beliefs regarding uncontrollability and danger (e.g., “I cannot stop this, I am losing my mind”). This secondary meta-worry fuels autonomic arousal, amplifies feelings of vulnerability, and leads to counterproductive suppression efforts that inevitably cause cognitive rebound effects, locking the individual into a self-perpetuating dysfunctional cognitive cycle.

7. Validity

The construct, convergent, discriminant, and predictive validity of the MCQ-30 have been verified across hundreds of empirical studies spanning both clinical psychiatric populations and diverse community cohorts.

Construct and Factorial Validity

Construct validity was initially established by Wells and Cartwright-Hatton (2004) using exploratory factor analysis (principal axis factoring with oblimin rotation) on a community sample of 182 adults. The resulting five factors mirrored the exact theoretical structure of the original 65-item instrument, explaining substantial portions of variance without problematic cross-loadings. Subsequent confirmatory factor analytic studies across independent samples (e.g., Spada et al., 2008) established that the five-factor model meets rigorous psychometric criteria across multiple goodness-of-fit indices.

Convergent Validity

Convergent validity has been repeatedly demonstrated through significant, robust correlations with validated instruments assessing affective and cognitive psychopathology:

• Pathological Worry: In the original validation study, the MCQ-30 total score correlated significantly with the Penn State Worry Questionnaire (PSWQ; $r = .53, p < .001$). The Negative Beliefs about Worry Concerning Uncontrollability and Danger subscale displayed the most pronounced association ($r = .64, p < .001$), supporting the theoretical link between meta-worry and chronic pathological worry.
• Trait and State Anxiety: Moderate to large correlations have been documented with the Spielberger State-Trait Anxiety Inventory (STAI; trait anxiety $r = .54$ to $.61$). The uncontrollability subscale consistently accounts for significant unique variance in trait anxiety scores even after controlling for baseline negative affectivity.
• Obsessive-Compulsive Symptoms: The MCQ-30 exhibits statistically significant relationships with the Padua Inventory and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Specifically, the Beliefs about the Need to Control Thoughts subscale ($r = .42$) and Cognitive Confidence subscale ($r = .46$) strongly predict compulsive checking and mental neutralization rituals.
• Depressive Rumination: In samples evaluating Major Depressive Disorder, the MCQ-30 correlates robustly with the Ruminative Responses Scale (RRS; $r = .48$ to $.65$). Longitudinal studies confirm that negative metacognitive beliefs prospectively predict the onset and maintenance of depressive episodes.

Discriminant and Incremental Validity

Discriminant validity is supported by hierarchical regression analyses demonstrating that metacognitive beliefs—most notably the uncontrollability and danger dimension—predict symptom severity over and above general neuroticism, demographic variables, and classic negative automatic thoughts. Furthermore, clinical trials show that successful Metacognitive Therapy specifically drives down MCQ-30 scores, whereas first-order cognitive therapy often alters thought content without equivalently reducing core metacognitive beliefs.

8. Reliability

The MCQ-30 demonstrates exceptional psychometric reliability across internal consistency, split-half reliability, and temporal test-retest stability.

Internal Consistency

In the seminal psychometric validation by Wells and Cartwright-Hatton (2004) involving 182 adult participants, the internal consistency (Cronbach’s $\alpha$) of the MCQ-30 full scale was documented at .93, reflecting superior overall reliability. The individual subscales demonstrated strong to excellent internal consistency:

• Positive Beliefs about Worry: $\alpha = .92$
• Negative Beliefs about Uncontrollability and Danger: $\alpha = .87$
• Cognitive Confidence: $\alpha = .84$
• Beliefs about the Need to Control Thoughts: $\alpha = .72$
• Cognitive Self-Consciousness: $\alpha = .72$

Independent cross-cultural validation studies have replicated these parameters with remarkable consistency. For example, Spada et al. (2008) evaluated a British non-clinical sample ($N = 728$) and observed subscale alphas ranging from .76 to .93, with a total scale alpha of .91. Similar internal consistency figures have been replicated in Turkish (Yilmaz et al., 2008; alphas .73–.86), Italian (Quattropani et al., 2014; alphas .74–.88), Spanish (Martín et al., 2014; alphas .71–.89), and Persian (Shirinzadeh et al., 2008) adaptations.

Test-Retest Stability

Temporal stability of the MCQ-30 was evaluated over intervals ranging from 22 to 118 days ($M = 46.8$ days, $n = 31$; Wells & Cartwright-Hatton, 2004). Subscale stability coefficients were:

• Cognitive Confidence: $r = .83, p < .001$
• Positive Beliefs about Worry: $r = .79, p < .001$
• Cognitive Self-Consciousness: $r = .84, p < .001$
• Need to Control Thoughts: $r = .75, p < .001$
• Negative Beliefs about Uncontrollability and Danger: $r = .59, p < .001$

While four of the five subscales demonstrated excellent stability ($r > .75$), the uncontrollability and danger subscale exhibited moderate temporal stability ($r = .59$). Researchers hypothesize that this subscale possesses both trait-like structural features and state-sensitive fluctuations tied to acute periods of life stress and episodic worry.

9. Factor Analysis

The factorial structure of the MCQ-30 has been scrutinized across numerous exploratory (EFA) and confirmatory factor analyses (CFA), confirming the presence of five clear latent dimensions that mirror the theoretical architecture of the original 65-item parent instrument.

Exploratory Factor Analysis (EFA)

In the scale development study (Wells & Cartwright-Hatton, 2004), the 65 items of the original MCQ were subjected to data reduction via principal axis factoring with direct oblimin rotation. The authors prioritized retaining items that exhibited high primary factor loadings ($> .40$), low secondary cross-loadings ($< .30$), and high conceptual coherence. This process isolated the top six items per factor, yielding a parsimonious 30-item instrument. The five extracted factors possessed eigenvalues ranging from 2.11 to 9.85, collectively accounting for 54.1% of the total variance.

Confirmatory Factor Analysis (CFA)

Subsequent large-scale validation studies have subjected the five-factor model to structural equation modeling. In a definitive structural investigation, Spada et al. (2008) administered the MCQ-30 to 728 non-clinical participants and tested alternative latent configurations: a single general factor model, an uncorrelated five-factor model, and a correlated five-factor model.

The correlated five-factor model demonstrated superior fit compared to rival specifications, fulfilling standard criteria for goodness-of-fit indices:

• Chi-Square / Degrees of Freedom Ratio ($\chi^2/df$): 2.41 (acceptable within the $< 3.0$ standard)
• Comparative Fit Index (CFI): .92 to .94
• Tucker-Lewis Index (TLI): .91 to .93
• Root Mean Square Error of Approximation (RMSEA): .044 to .053 (90% CI [.041, .057]), indicating excellent approximation to the population covariance matrix
• Standardized Root Mean Square Residual (SRMR): .048 to .054

Item-to-factor standardized factor loadings in CFA models consistently range between .52 and .88, with zero cross-loadings exceeding theoretical tolerances. Invariance testing across biological sex and age brackets confirms metric and scalar invariance, establishing that the MCQ-30 measures identical latent constructs with uniform measurement thresholds across diverse demographic strata.

10. Instrument / Measurement Tool

The Metacognition Questionnaire-30 is structured as follows:

• Instrument Type: Standardized self-report psychometric rating scale
• Target Population: Adults (aged 18 and older); validated adolescent adaptations (MCQ-A) are available separately
• Administration Format: Paper-and-pencil, computer-based, or online clinical assessment systems
• Administration Time: Approximately 5 to 8 minutes
• Item Count: Exactly 30 items, systematically distributed into 5 subscales of 6 items each
• Authentic Response Scale: 4-point Likert scale:
  • 1 = Do not agree
  • 2 = Agree slightly
  • 3 = Agree moderately
  • 4 = Agree very much
• Reverse-Scoring: None. All 30 items are directly keyed and scored from 1 to 4.
• Subscale Item Allocation:
  • Positive Beliefs about Worry: Items 1, 7, 10, 19, 23, 28
  • Negative Beliefs about Worry Concerning Uncontrollability and Danger: Items 2, 4, 9, 11, 15, 21
  • Cognitive Confidence: Items 8, 14, 17, 24, 26, 29
  • Beliefs about the Need to Control Thoughts: Items 6, 13, 20, 22, 25, 27
  • Cognitive Self-Consciousness: Items 3, 5, 12, 16, 18, 30
• Scoring and Interpretation:
  • Subscale Scores: Summing the 6 items for each subscale produces raw subscale scores ranging from 6 to 24.
  • Total Score: Summing all 30 items produces an overall metacognitive dysfunction score ranging from 30 to 120.
  • Directionality: Higher scores consistently reflect greater levels of unhelpful or dysfunctional metacognitions. Elevated scores on Cognitive Confidence signify increased distrust of memory and mental functioning.

11. Permissions & Fee and Test Year

The Metacognition Questionnaire-30 was originally published in 2004 in the peer-reviewed journal Behaviour Research and Therapy.

• Copyright & Ownership: The instrument is copyrighted by the original authors (Adrian Wells and Sam Cartwright-Hatton) and Elsevier Ltd.
• Research & Non-Commercial Clinical Use: The MCQ-30 is widely accessible for academic, clinical, and non-commercial scientific research. Researchers and clinicians may administer the questionnaire in therapeutic practices and scholarly investigations without royalty fees, provided proper formal academic citation is rendered to the authors’ 2004 seminal publication.
• Commercial Applications: Commercial use, deployment in proprietary digital platforms, or inclusion in revenue-generating commercial products requires written permission and formal licensing from the primary copyright holder and Elsevier.

12. References

Cartwright-Hatton, S., & Wells, A. (1997). Beliefs about worry and intrusions: The Meta-Cognitions Questionnaire and its correlates. Journal of Anxiety Disorders, 11(3), 279–296. https://doi.org/10.1016/S0887-6185(97)00011-X

Martín, J., Padierna, A., Unzurrunzaga, A., González, N., & Quintana, J. M. (2014). Adaptation and validation of the Metacognition Questionnaire (MCQ-30) in Spanish clinical and non-clinical samples. Journal of Affective Disorders, 167, 274–280. https://doi.org/10.1016/j.jad.2014.06.012

Quattropani, M. C., Lenzo, V., Mucciardi, M., & Toffle, M. E. (2014). Psychometric properties of the Italian version of the Short Form of the Metacognitions Questionnaire (MCQ-30). Bollettino di Psicologia Applicata, 269, 29–41.

Shirinzadeh, D. S., Goodarzi, M. A., Rahimi, C., & Naziri, G. (2008). The study of factor structure, validity and reliability of Metacognition Questionnaire-30. Journal of Psychology, 12(4), 445–461.

Spada, M. M., Mohiyeddini, C., & Wells, A. (2008). Measuring metacognitions: Psychometric properties of the Metacognitions Questionnaire-30 (MCQ-30) in a large non-clinical UK sample. Behaviour Research and Therapy, 46(6), 761–769. https://doi.org/10.1016/j.brat.2008.03.006

Wells, A. (2000). Emotional Disorders and Metacognition: Innovative Cognitive Therapy. John Wiley & Sons.

Wells, A. (2009). Metacognitive Therapy for Anxiety and Depression. Guilford Press.

Wells, A., & Cartwright-Hatton, S. (2004). A short form of the metacognitions questionnaire: Properties of the MCQ-30. Behaviour Research and Therapy, 42(4), 385–396. https://doi.org/10.1016/S0005-7967(03)00147-5

Wells, A., & Matthews, G. (1994). Attention and Emotion: A Clinical Perspective. Lawrence Erlbaum Associates.

Wells, A., & Matthews, G. (1996). Modelling cognition in emotional disorder: The S-REF model. Behaviour Research and Therapy, 34(11–12), 881–888. https://doi.org/10.1016/S0005-7967(96)00050-2

Yilmaz, A. E., Gençöz, T., & Wells, A. (2008). Psychometric properties of the Turkish version of the Metacognitions Questionnaire-30. Cognitive Therapy and Research, 32(6), 830–840. https://doi.org/10.1007/s10608-007-9140-5

13. Items of the Scale